GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » AegirBio AB (GREY:AEGBF) » Definitions » Common Stock

AegirBio AB (AegirBio AB) Common Stock : $0.24 Mil (As of Mar. 2024)


View and export this data going back to 2023. Start your Free Trial

What is AegirBio AB Common Stock?

AegirBio AB's quarterly common stock increased from Sep. 2023 ($0.19 Mil) to Dec. 2023 ($0.24 Mil) but then declined from Dec. 2023 ($0.24 Mil) to Mar. 2024 ($0.24 Mil).

AegirBio AB's annual common stock increased from Dec. 2021 ($0.15 Mil) to Dec. 2022 ($0.16 Mil) and increased from Dec. 2022 ($0.16 Mil) to Dec. 2023 ($0.24 Mil).


AegirBio AB Common Stock Historical Data

The historical data trend for AegirBio AB's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AegirBio AB Common Stock Chart

AegirBio AB Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Common Stock
0.05 0.11 0.15 0.16 0.24

AegirBio AB Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.20 0.19 0.19 0.24 0.24

AegirBio AB Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.


AegirBio AB (AegirBio AB) Business Description

Traded in Other Exchanges
Address
Scheelevagen 27, Lund, SWE, SE-223 63
AegirBio AB is a Swedish diagnostic company that offers tests to monitor and optimize the dosage of biological drugs via its patented technology platform. The company's products include Monator - drug monitoring of tysabri in MS, Veritope, and Magniareader.

AegirBio AB (AegirBio AB) Headlines

No Headlines